CONSOLIDATED STATEMENTS OF CASH FLOW (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Operating Activities
Net income (loss)	$ 23,813	$ 14,802	$ (64,139)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Provision for loan losses	17,800	35,250	46,310
Depreciation expense	5,074	5,276	5,351
Amortization of mortgage servicing rights	1,388	1,424	2,317
Change in valuation allowance on mortgage servicing rights	(45)	(132)	(600)
Securities amortization, net	2,693	1,794	(72)
Amortization of purchased intangible assets	1,939	2,066	2,199
Earnings on cash surrender value of life insurance policies	(1,200)	(1,246)	(890)
Gain on life insurance benefit	(141)	(67)	(128)
Gain on sale of insurance related business line		(988)
Securities gains	(11,357)	(2,979)	(1,263)
Gain on loans sold	(3,494)	(5,152)	(5,548)
Loans originated for sale	(195,344)	(274,111)	(419,192)
Proceeds from loan sales	188,063	278,546	424,559
Stock based compensation expense	173	114	115
Director retainer fee expense	220
Gain/(loss) on sale and write-down of OREO	2,744	1,097	(200)
Goodwill impairment			80,310
Change in other assets and liabilities	3,734	6,940	(33,045)
Net cash provided by operating activities	36,060	62,634	36,084
Investing Activities
Net change in time deposits			116
Purchases of securities available for sale	(527,834)	(363,844)	(451,603)
Proceeds from calls, maturities, and payments on securities available for sale	120,588	157,154	172,390
Proceeds from sales of securities available for sale	366,559	111,564	93,855
Loan originations and payments, net	102,983	154,068	124,944
Purchases of premises and equipment	(6,865)	(4,660)	(2,490)
Proceeds from sale and write-down of OREO	16,346	8,928	7,566
Sale of insurance related business line		2,000
Proceeds from redemption of restricted stock	3,646	7,857	2,362
Proceeds from life insurance benefit	893	124	442
Cash received from bank acquisitions, net			17,566
Net cash provided (used) by investing activities	76,316	73,191	(34,852)
Financing Activities
Net change in deposits	(51,664)	(59,086)	173,291
Net change in other borrowings	(7,392)	(14,450)	(36,817)
Proceeds from FHLB advances	15,000		50,000
Repayment of FHLB advances	(15,638)	(70,200)	(260,902)
Cash dividends on preferred stock	(2,850)	(2,850)	(2,367)
Cash dividends on common stock	(807)	(805)	(5,135)
Issuance of preferred shares, net of issuance costs			55,783
Issuance of warrants to purchase common stock			1,116
Net cash provided (used) by financing activities	(63,351)	(147,391)	(25,031)
Net change in cash and cash equivalents	49,025	(11,566)	(23,799)
Cash and cash equivalents, beginning of year	60,123	71,689	95,488
Cash and cash equivalents, end of year	109,148	60,123	71,689
Supplemental cash flow information
Interest paid	23,263	34,714	47,011
Income taxes paid/(refunded)	2,672	(1,675)	1,820
Supplemental non cash disclosure
Loan balances transferred to foreclosed real estate	$ 23,093	$ 11,115	$ 11,915